Genesis Research Offers Free EVID AI Access Through 2026

Free access through 2026 sounds like a giveaway. The better read is that Genesis is betting on workflow lock-in. Once a team builds its evidence processes inside EVID AI, switching costs rise. The platform becomes the default environment for HEOR and RWE work. That makes the free period a strategic investment in adoption, not just a trial.

What would confirm that bet? If organizations that start with free access later pay for expert support or expanded features. Genesis keeps expert services separate from the platform offer, so the revenue path is clear. What would weaken it? If users treat the platform as a one-off tool and leave after the free period ends. The company did not disclose how many organizations have already signed up.

Approved users get free access through Dec. 31, 2026. Expert support for protocol design, search strategy, screening, and interpretation is available separately, priced per project. Interested researchers can request access through the Genesis website.

Genesis Research Group is a global life sciences consulting firm focused on evidence generation, health economics, market access, and pricing strategy. The company said the free access program reflects its view that better evidence synthesis leads to better decisions across development, launch, and commercialization.